Breaking News Instant updates and real-time market news.

ACHN

Achillion

$4.43

-0.38 (-7.90%)

06:02
08/11/17
08/11
06:02
08/11/17
06:02

Leerink talk with opinion leader suggests Achillion selloff overdone

Leerink analyst Joseph Schwartz says his talk with a key opinion leader who has extensive experience in paroxysmal nocturnal hemoglobinuria clinical development and patient care suggests the recent selloff in shares of Achillion Pharmaceuticals is overdone. The feedback indicates that investors are overemphasizing lactate dehydrogenase data without assigning much credit to the promise that other parameters, such as hemoglobin, fatigue score, and PNH clone size, seem to suggest, Schwartz tells investors in a research note. He reiterates an Overweight rating on shares of Achillion.

  • 16

    Aug

ACHN Achillion
$4.43

-0.38 (-7.90%)

08/10/17
08/10/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Unilever (UN, UL) downgraded to Underperform from Sector Perform at RBC Capital with analyst James Edwardes Jones citing valuation and his belief that the company may not meet its 2020 targets. 2. Masonite (DOOR) downgraded to Equal Weight from Overweight at Stephens. 3. Synacor (SYNC) downgraded to Hold from Buy at Craig-Hallum with analyst Jason Kreyer saying he is "unequivocally" disappointed that the AT&T (T)portal launch has not yet monetized at a rate anticipated. 4. NetEase (NTES) downgraded to Underperform from Outperform at CLSA. 5. Achillion (ACHN) downgraded to Neutral from Outperform at Baird with analyst Brian Skorney saying the PNH data reported earlier this week was better than expected but he is not convinced that given the drug's therapeutic window, dosing, and impact on LDH that it can be competitive with Soliris. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/17
BARD
08/10/17
DOWNGRADE
Target $5
BARD
Neutral
Achillion downgraded to Neutral at Baird
As reported previously, Baird analyst Brian Skorney downgraded Achillion to Neutral from Outperform. He said the PNH data reported earlier this week was better than expected but he is not convinced that given the drug's therapeutic window, dosing, and impact on LDH that it can be competitive with Soliris. Skorney maintained his $5 price target on Achillion shares.
08/10/17
MAXM
08/10/17
NO CHANGE
Target $7
MAXM
Buy
Achillion price target raised to $7 from $5 at Maxim
Maxim analyst Jason Kolbert is introducing estimates for paroxysmal nocturnal hemoglobinuria in his model for Achillion after the company reported "proof of concept" news for its Factor D program. Adding in the potential for an eventual PHH indication leads him to raise his price target on Achillion shares to $7 from $5. He keeps a Buy rating on the stock.
08/10/17
BARD
08/10/17
DOWNGRADE
BARD
Neutral
Achillion downgraded to Neutral from Outperform at Baird

TODAY'S FREE FLY STORIES

BXP

Boston Properties

$122.03

-0.4 (-0.33%)

07:46
08/17/17
08/17
07:46
08/17/17
07:46
Downgrade
Boston Properties rating change  »

Boston Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LFC

China Life Insurance

$15.24

0.04 (0.26%)

07:46
08/17/17
08/17
07:46
08/17/17
07:46
Downgrade
China Life Insurance rating change  »

China Life Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSY

Hershey

$106.04

0.14 (0.13%)

07:46
08/17/17
08/17
07:46
08/17/17
07:46
Upgrade
Hershey rating change  »

Hershey upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RVLT

Revolution Lighting

$6.82

-0.03 (-0.44%)

07:42
08/17/17
08/17
07:42
08/17/17
07:42
Hot Stocks
Revolution Lighting awarded DoD contract »

Revolution Lighting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOLD

Amicus

$12.60

0.31 (2.52%)

, IRWD

Ironwood

$14.92

0.06 (0.40%)

07:42
08/17/17
08/17
07:42
08/17/17
07:42
Recommendations
Amicus, Ironwood, Otonomy, Sarepta, Ignyta analyst commentary  »

JPMorgan lists top SMID…

FOLD

Amicus

$12.60

0.31 (2.52%)

IRWD

Ironwood

$14.92

0.06 (0.40%)

OTIC

Otonomy

$19.35

-0.1 (-0.51%)

SRPT

Sarepta

$37.43

0.72 (1.96%)

RXDX

Ignyta

$9.80

0.1 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 26

    Sep

CSVI

Computer Services

$46.50

0.45 (0.98%)

07:41
08/17/17
08/17
07:41
08/17/17
07:41
Hot Stocks
Computer Services announces retirement of president R. Stanley Eckenberg »

Computer Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROIC

Retail Opportunity

$20.14

0.09 (0.45%)

07:40
08/17/17
08/17
07:40
08/17/17
07:40
Upgrade
Retail Opportunity rating change  »

Retail Opportunity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$159.50

1.75 (1.11%)

07:39
08/17/17
08/17
07:39
08/17/17
07:39
Hot Stocks
Alibaba: 'The numbers speak for themselves' »

Alibaba said on its Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 18

    Aug

AAPL

Apple

$160.94

-0.68 (-0.42%)

07:38
08/17/17
08/17
07:38
08/17/17
07:38
Periodicals
Apple Watch may not support voice calls at launch, AI reports »

The new LTE-connected…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

WMT

Wal-Mart

$80.98

0.21 (0.26%)

07:35
08/17/17
08/17
07:35
08/17/17
07:35
Hot Stocks
Breaking Hot Stocks news story on Wal-Mart »

Wal-Mart drops 2.3% in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 16

    Nov

  • 20

    Feb

TDOC

Teladoc

$30.05

-1.15 (-3.69%)

07:35
08/17/17
08/17
07:35
08/17/17
07:35
Recommendations
Teladoc analyst commentary  »

Teladoc to benefit from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 06

    Sep

  • 11

    Sep

AERI

Aerie Pharmaceuticals

$52.20

-0.2 (-0.38%)

07:35
08/17/17
08/17
07:35
08/17/17
07:35
Recommendations
Aerie Pharmaceuticals analyst commentary  »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 28

    Feb

BABA

Alibaba

$159.50

1.75 (1.11%)

, MU

Micron

$30.69

1.01 (3.40%)

07:35
08/17/17
08/17
07:35
08/17/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BABA

Alibaba

$159.50

1.75 (1.11%)

MU

Micron

$30.69

1.01 (3.40%)

FCX

Freeport McMoRan

$14.77

0.8 (5.73%)

VALE

Vale

$10.10

0.32 (3.27%)

RIG

Transocean

$7.58

-0.33 (-4.17%)

MPC

Marathon Petroleum

$51.06

-0.83 (-1.60%)

COTY

Coty

$19.67

0.11 (0.56%)

PAGP

Plains GP Holdings

$20.35

-0.46 (-2.21%)

ETSY

Etsy

$15.60

-0.04 (-0.26%)

FOLD

Amicus

$12.60

0.31 (2.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 18

    Aug

  • 22

    Aug

  • 29

    Aug

  • 29

    Aug

  • 06

    Sep

  • 08

    Nov

REG

Regency Centers

$65.52

0.46 (0.71%)

07:34
08/17/17
08/17
07:34
08/17/17
07:34
Upgrade
Regency Centers rating change  »

Regency Centers upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COMM

CommScope

$32.85

0.01 (0.03%)

07:34
08/17/17
08/17
07:34
08/17/17
07:34
Upgrade
CommScope rating change  »

CommScope upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

MSG

Madison Square Garden

$217.42

1.33 (0.62%)

07:33
08/17/17
08/17
07:33
08/17/17
07:33
Earnings
MSG reports Q4 EPS ($3.58), may not compare to consensus ($1.39) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

ARAY

Accuray

$4.00

-0.1 (-2.44%)

07:32
08/17/17
08/17
07:32
08/17/17
07:32
Hot Stocks
Accuray's Radixact system used by Summit Cancer Center-Boise for the first time »

Accuray and the Summit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

AMOV

America Movil, also tag AMX

$18.51

-0.07 (-0.38%)

, AMX

America Movil, also tag AMOV

$18.82

0.22 (1.18%)

07:32
08/17/17
08/17
07:32
08/17/17
07:32
Periodicals
Mexican Supreme Court rules for America Movil on interconnection fees, WSJ says »

Mexico's Supreme…

AMOV

America Movil, also tag AMX

$18.51

-0.07 (-0.38%)

AMX

America Movil, also tag AMOV

$18.82

0.22 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDEN

Golden Entertainment

$21.41

0.23 (1.09%)

07:31
08/17/17
08/17
07:31
08/17/17
07:31
Hot Stocks
Golden Entertainment completes syndication of financing to fund American deal »

Golden Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$8.65

0.06 (0.70%)

, CBI

CB&I

$9.97

-1.22 (-10.90%)

07:30
08/17/17
08/17
07:30
08/17/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

PBR

Petrobras

$8.65

0.06 (0.70%)

CBI

CB&I

$9.97

-1.22 (-10.90%)

URBN

Urban Outfitters

$19.76

2.94 (17.48%)

CL

Colgate-Palmolive

$71.93

0.13 (0.18%)

AXON

Axovant Sciences

$21.80

-0.83 (-3.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

CSCO

Cisco

$32.34

0.25 (0.78%)

07:28
08/17/17
08/17
07:28
08/17/17
07:28
Recommendations
Cisco analyst commentary  »

Cisco stock likely range…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

LB

L Brands

$38.95

0.5 (1.30%)

07:28
08/17/17
08/17
07:28
08/17/17
07:28
Recommendations
L Brands analyst commentary  »

L Brands share losses may…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

CSCO

Cisco

$32.34

0.25 (0.78%)

07:28
08/17/17
08/17
07:28
08/17/17
07:28
Recommendations
Cisco analyst commentary  »

Cisco 'slowly moving…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

CCL

Carnival

$68.87

0.16 (0.23%)

07:28
08/17/17
08/17
07:28
08/17/17
07:28
Recommendations
Carnival analyst commentary  »

Carnival price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTNA

Quantenna Communications

$17.79

-0.23 (-1.28%)

07:27
08/17/17
08/17
07:27
08/17/17
07:27
Conference/Events
Quantenna Communications management to meet with Deutsche Bank »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 23

    Aug

  • 12

    Sep

  • 08

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.